Bio-Techne® empowers the Neuroscience community by providing the high-quality reagents and innovative instruments that scientists need to further their research.
Bio-Techne is headquartered in Minneapolis, Minnesota and employs over 3,000 people globally at 34 locations worldwide. As a global developer, manufacturer and supplier of high-quality reagents, analytical instruments and precision diagnostics, Bio-Techne has an extensive catalog of over 500,000 products. Incorporated in 1981 as R&D Systems, the company changed its name to Bio-Techne in 2014. Our growth has been accelerated through acquisitions, organic investments, diversification of our customer base and expansion into new markets. In fiscal year 2023, Bio-Techne delivered net sales of over $1.1 billion. Bio-Techne includes the following brands: ACD, Asuragen, ExosomeDx, Lunaphore, Novus Biologicals, ProteinSimple, R&D Systems and Tocris Bioscience.
Brands: R&D Systems™, Novus Biologicals™, Tocris Bioscience™, ProtienSimple™, Advanced Cell Diagnostics™, Exosome Diagnostics™ and Asuragen®.